Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. (2021)
Attributed to:
Psychosis Immune Mechanism Stratified Medicine Study (PIMS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.psyneuen.2021.105295
PubMed Identifier: 34119855
Publication URI: http://europepmc.org/abstract/MED/34119855
Type: Journal Article/Review
Volume: 131
Parent Publication: Psychoneuroendocrinology
ISSN: 0306-4530